Morphological asymmetry and broiler welfare

Health status, feed conversion ratio, and mortality are long known broiler chicken production indicators. However, further parameters are required by today's demanding meat markets, as these indicators are not sufficiently accurate to determine flock overall welfare. Morphological asymmetry has been pointed as an alternative welfare indicator as it reflects the ability of the bird to cope with the challenges that rearing conditions may impose. This study aimed at evaluating the possibility of using morphological asymmetry as a welfare indicator. Broilers from 28 to 42 days of age were used in the trial. Birds were randomly selected in a commercial poultry farm and transported to the laboratory. They walked over the force measurement platform in order to determined their feet force as a percentage of body weight. The following body parts of the live birds were measured by two different operators using a digital caliper: tarsometatarsus length, outertoe length, midtoe length, and backtoe length. In the corresponding carcasses, the following traits were measured: wattle width, eye length, and first secondary feather length. Data were submitted to statistical analyses and no correlation was found between specific feet trait measurements and walking ability. Considering the time budget involved in measuring morphological asymmetry, this procedure did not appear to be a practically feasible welfare indicator.209213Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq

Essential Medicines at the National Level : The Global Asthma Network's Essential Asthma Medicines Survey 2014

Patients with asthma need uninterrupted supplies of affordable, quality-assured essential medicines. However, access in many low- and middle-income countries (LMICs) is limited. The World Health Organization (WHO) Non-Communicable Disease (NCD) Global Action Plan 2013-2020 sets an 80% target for essential NCD medicines' availability. Poor access is partly due to medicines not being included on the national Essential Medicines Lists (EML) and/or National Reimbursement Lists (NRL) which guide the provision of free/subsidised medicines. We aimed to determine how many countries have essential asthma medicines on their EML and NRL, which essential asthma medicines, and whether surveys might monitor progress. A cross-sectional survey in 2013-2015 of Global Asthma Network principal investigators generated 111/120 (93%) responses41 high-income countries and territories (HICs); 70 LMICs. Patients in HICs with NRL are best served (91% HICs included ICS (inhaled corticosteroids) and salbutamol). Patients in the 24 (34%) LMICs with no NRL and the 14 (30%) LMICs with an NRL, however no ICS are likely to have very poor access to affordable, quality-assured ICS. Many LMICs do not have essential asthma medicines on their EML or NRL. Technical guidance and advocacy for policy change is required. Improving access to these medicines will improve the health system's capacity to address NCDs.Peer reviewe